JP2012532167A - インターフェロンβの精製方法 - Google Patents

インターフェロンβの精製方法 Download PDF

Info

Publication number
JP2012532167A
JP2012532167A JP2012518819A JP2012518819A JP2012532167A JP 2012532167 A JP2012532167 A JP 2012532167A JP 2012518819 A JP2012518819 A JP 2012518819A JP 2012518819 A JP2012518819 A JP 2012518819A JP 2012532167 A JP2012532167 A JP 2012532167A
Authority
JP
Japan
Prior art keywords
ifn
chromatography
container
affinity chromatography
hydrophobic interaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012518819A
Other languages
English (en)
Japanese (ja)
Inventor
アーノルド，ステファン
シェッカーマン，クリスチャン
Original Assignee
バイオジェネリクス アーゲー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by バイオジェネリクス アーゲー filed Critical バイオジェネリクス アーゲー
Publication of JP2012532167A publication Critical patent/JP2012532167A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/565—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
JP2012518819A 2009-07-07 2010-07-07 インターフェロンβの精製方法 Pending JP2012532167A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102009032179A DE102009032179A1 (de) 2009-07-07 2009-07-07 Verfahren zur Reinigung von Interferon beta
DE102009032179.9 2009-07-07
PCT/EP2010/004130 WO2011003600A1 (en) 2009-07-07 2010-07-07 METHOD FOR THE PURIFICATION OF INTERFERON-β

Publications (1)

Publication Number Publication Date
JP2012532167A true JP2012532167A (ja) 2012-12-13

Family

ID=42562473

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012518819A Pending JP2012532167A (ja) 2009-07-07 2010-07-07 インターフェロンβの精製方法

Country Status (5)

Country Link
EP (1) EP2451470A1 (de)
JP (1) JP2012532167A (de)
DE (1) DE102009032179A1 (de)
EA (1) EA201290040A1 (de)
WO (1) WO2011003600A1 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021010638A1 (ko) * 2019-07-18 2021-01-21 에이비온 주식회사 2당화된 인터페론-베타 단백질의 정제 방법

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009505645A (ja) * 2005-08-26 2009-02-12 アレス トレーディング ソシエテ アノニム グリコシル化されたインターフェロンベータの調製方法
JP2009518361A (ja) * 2005-12-09 2009-05-07 アレス トレーディング ソシエテ アノニム Ｆｓｈ又はｆｓｈ変異体を精製するための方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5564799A (en) 1978-11-07 1980-05-15 Toray Ind Inc Multi-stage concentration and purification of interferon originated from human fibroblast
CH648331A5 (de) 1979-07-31 1985-03-15 Hoffmann La Roche Homogenes fibroblasten-interferon und dessen herstellung.
US4278661A (en) 1979-10-12 1981-07-14 E. I. Du Pont De Nemours And Company Purification of interferon
NL7907791A (nl) 1979-10-23 1981-04-27 Stichting Rega V Z W Werkwijze voor het zuiveren van interferon.
AU538665B2 (en) 1979-10-30 1984-08-23 Juridical Foundation, Japanese Foundation For Cancer Research Human interferon dna
DK170476B1 (da) 1980-04-03 1995-09-11 Biogen Inc Rekombinant DNA-molekyle, uni-cellulær vært transformeret med mindst ét rekombinant DNA-molekyle, fremgangsmåde til transformering af en uni-cellulær vært, samt fremgangsmåder til fremstilling af et polpeptid, der udviser den immunologiske eller biologiske aktivitet af human beta-interferon
DE3273787D1 (en) 1981-02-04 1986-11-20 Japan Found Cancer Human interferon-beta gene
JPS58201794A (ja) 1982-05-17 1983-11-24 Toray Ind Inc ヒトインターフェロンβの濃縮精製法
US4992271A (en) 1982-09-23 1991-02-12 Cetus Corporation Formulation for lipophilic IL-2 proteins
CA1231306A (en) 1983-03-03 1988-01-12 Erich Hochuli Purification of interferon
US4894330A (en) 1986-12-23 1990-01-16 Cetus Corporation Purification of recombinant beta-interferon incorporating RP-HPLC
DE3712564A1 (de) 1987-04-14 1988-11-24 Bioferon Biochem Substanz Verfahren zur konstruktion einer animalen zellinie fuer die herstellung von humanem interferon-beta
US5169936A (en) * 1989-04-14 1992-12-08 Biogen, Inc. Protein purification on immobilized metal affinity resins effected by elution using a weak ligand
IT1240612B (it) 1990-03-16 1993-12-17 Sclavo Spa Procedimento di purificazione del b-interferone umano ricombinante
DE4128319A1 (de) 1991-08-27 1993-03-04 Bioferon Biochem Substanz Neues rekombinantes human-ifn-beta, verfahren zu dessen herstellung und dieses enthaltende pharmazeutische zubereitungen
TR199901968T2 (xx) 1996-12-24 1999-12-21 Biogen, Inc. Sabit s�v� interferon form�lleri.
EP1224940B2 (de) 1997-09-23 2010-08-11 Rentschler Biotechnologie GmbH Flüssige Interferon-Beta Formulierungen
SK286217B6 (sk) * 1998-04-28 2008-05-06 Laboratoires Serono Sa Polyol-interferón-ß konjugát, spôsob jeho výroby a farmaceutický prostriedok s jeho obsahom
ITBO20010426A1 (it) 2001-07-06 2003-01-06 Alfa Wassermann Spa Processo per la purificazione di proteine farmacologicamente attive mediante cromatografia in scambio cationico
AU2003303635B2 (en) * 2002-12-26 2009-07-23 Mountain View Pharmaceuticals, Inc. Polymer conjugates of interferon-beta with enhanced biological potency
DE102007050165B4 (de) * 2007-10-19 2010-06-17 Stiftung Tierärztliche Hochschule Hannover Stabilisierte Lösung, Verfahren zu deren Herstellung sowie deren Verwendung und Arzneimittel in Form einer stabilisierten Lösung
EP2245044A2 (de) * 2008-01-18 2010-11-03 F. Hoffmann-La Roche AG Reinigung nicht-glycosylierter proteine
DE102008051574A1 (de) * 2008-10-14 2010-04-15 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Verfahren zur Herstellung von Interferon-beta und deren Varianten

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009505645A (ja) * 2005-08-26 2009-02-12 アレス トレーディング ソシエテ アノニム グリコシル化されたインターフェロンベータの調製方法
JP2009518361A (ja) * 2005-12-09 2009-05-07 アレス トレーディング ソシエテ アノニム Ｆｓｈ又はｆｓｈ変異体を精製するための方法

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021010638A1 (ko) * 2019-07-18 2021-01-21 에이비온 주식회사 2당화된 인터페론-베타 단백질의 정제 방법
JP2022541112A (ja) * 2019-07-18 2022-09-22 アビオン インク． 二糖化インターフェロンβタンパク質の精製方法
JP7425936B2 (ja) 2019-07-18 2024-02-01 アビオン インク． 二糖化インターフェロンβタンパク質の精製方法

Also Published As

Publication number Publication date
EP2451470A1 (de) 2012-05-16
DE102009032179A1 (de) 2011-01-13
WO2011003600A8 (en) 2011-09-01
WO2011003600A1 (en) 2011-01-13
EA201290040A1 (ru) 2012-07-30

Similar Documents

Publication Publication Date Title
US10980885B2 (en) Method of reducing formation of etanercept aggregates or fragments
US11000588B2 (en) Etanercept formulations stabilized with sodium chloride
US20120177603A1 (en) Method for the purification of interferon-b
JP2012532167A (ja) インターフェロンβの精製方法

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20130531

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A712

Effective date: 20140808

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140916

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20150303